Content is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional
Retrieved from Wang, C., Tariq, A., & Chandra, S
Medullary thyroid cancer makes up a small percentage of our total thyroid cancer patients, maybe about 3 to 10%. While researchers have found no incidence to date of semaglutide causing any kind of thyroid cancer in humans, the earliest laboratory research identifying a correlation between semaglutide and medullary thyroid cancers was strong enough for the FDA to warrant a boxed warning
Makhoul focuses on whole-person care, creating personalized weight management plans that support overall health and related conditions such as high blood pressure, high cholesterol, and prediabetes